Consumer medicine information

Panamax

Paracetamol

BRAND INFORMATION

Brand name

Panamax

Active ingredient

Paracetamol

Schedule

S2 | S3

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Panamax.

What is in this leaflet

This leaflet answers some common questions about Panamax tablets, elixir and 240 elixir. It does not contain all the available information.

It does not take the place of talking to your pharmacist or doctor.

All medicines have benefits and risks. In deciding to give you Panamax, your pharmacist or doctor has weighed the risks of taking Panamax against the benefits it will have for you.

If you have concerns about taking this medicine, ask your pharmacist or doctor.

Keep this information with the medicine. You may need to read it again.

What is Panamax used for

Panamax is used to relieve pain and fever in adults (including arthritis, headache and muscular pain) and children (including teething, earache and immunisation).

Panamax works to stop the pain messages from getting through to the brain. Panamax also acts in the brain to reduce fever.

Ask your pharmacist or doctor if you have any questions about this medicine.

Your pharmacist or doctor may have prescribed this medicine for another use. If you want more information, ask your pharmacist or doctor.

Before you take it

When you must not take it

You should not take Panamax if you are allergic to paracetamol or any of the ingredients listed under "Product Description".

The symptoms of an allergic reaction may include:

  • shortness of breath
  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue or other parts of the body
  • rash, itching or hives on the skin

Do not take this medicine if you have liver or kidney problems.

Do not take Panamax if you have glucose-6-phosphate-dehydrogenase deficiency (an enzyme deficiency).

Do not use Panamax after the expiry date (EXP) printed on the pack or bottle.

Do not use Panamax if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal.

If you are not sure whether you should start taking this medicine, talk to your pharmacist or doctor.

Before you start to take it

You must tell your pharmacist or doctor if you have or have had any of the following medical conditions:

  • You have allergies to any ingredients listed under "Product Description" at the end of this leaflet
  • You have allergies to aspirin or any other NSAID medicine
  • You have liver or kidney problems
  • You have low glutathione reserves
  • You have Gilbert's syndrome
  • Acute breathing difficulties such as bronchitis, unstable asthma or emphysema
  • You drink large quantities of alcohol

Tell your pharmacist or doctor about taking paracetamol if you are pregnant or plan to become pregnant, or breastfeeding. Panamax may be used during pregnancy and if you are breastfeeding. However, it is recommended that non-drug therapy such as rest and massage be tried first. If Panamax is needed during pregnancy, it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.

Taking other medicines

You should tell your pharmacist or doctor if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop.

Some medicine and Panamax may interfere with each other. These include:

  • Any medicines which thin the blood, for example warfarin
  • Medicines to treat epilepsy
  • Metoclopramide or domperidone, medicines used to control nausea and vomiting
  • Propantheline, a drug used to treat stomach ulcers
  • Other pain relief medication
  • Alcohol and medicines containing alcohol (ethanol) eg some cough syrups
  • Medicines used to treat depression
  • Medicines used to aid sleep
  • Chloramphenicol, an antibiotic used to treat ear and eye infections
  • Flucloxacillin, zidovudine and rifampicin, drugs used to treat infections
  • Probenecid, a drug used to treat high uric acid levels in the blood associated with gout
  • Cholestyramine, a drug used to reduce blood cholesterol
  • Chelating resin

These medicines may be affected by Panamax or may affect how well Panamax works.

Your pharmacist or doctor can tell you what to do if you are taking any of these medicines.

If you have not told your pharmacist or doctor about any of these things, tell him/her before you take Panamax.

How to take Panamax

The label on the pack or bottle will tell you how to take your medicine and how often. If you are unsure about the directions ask your pharmacist or doctor.

There are three different Panamax products:

  • Panamax Tablets,
  • Panamax Elixir and
  • Panamax 240 Elixir.

The dose will be different depending upon which product you are taking.

Panamax Tablets

The usual dose is:

Adults:
1 to 2 tablets

This dosage may be repeated every 4 to 6 hours if necessary.

You should not take more than 8 tablets in 24 hours.

Children (7-12 years):
Half (1/2) to 1 tablet.

This dosage may be repeated every 4 to 6 hours if necessary.

Children should not take more than 4 tablets in 24 hours.

Panamax tablets are not recommended for children under 7 years.

Swallow tablets whole with a little water or other liquid.

Panamax Elixir

The usual dose is

Infants:
1 to 3 months: (4 - 6 kg)
2 to 4 mL;

3 to 6 months: (6 - 8 kg)
4 to 5 mL;

6 to 12 months: (8 - 10 kg)
5 to 6 mL.

Children:
1 to 2 years: (10 - 12 kg)
6 to 8 mL;

2 to 4 years: (12 - 16 kg)
8 to 10 mL;

4 to 6 years: (16 - 20 kg)
10 to 13 mL;

6 to 8 years: (20 - 25 kg)
13 to 16 mL;

8 to 10 years: (25 - 32 kg)
16 to 20 mL;

10 to 12 years: (32 - 41 kg)
20 to 26 mL.

This dosage may be repeated every 4 to 6 hours if necessary.

Do not give more than 4 doses in 24 hours.

Panamax Elixir is not recommended for infants under 1 month.

It can be given in water.

Panamax 240 Elixir

Children:
5 to 6 years: (18 - 20 kg)
6 mL;

6 to 8 years: (20 to 25 kg)
6 to 8 mL;

8 to 10 years: (25 - 32 kg)
8 to 10 mL;

10 to 12 years: (32 - 41 kg)
10 to 12 mL.

Do not give more than 4 doses in 24 hours.

Adults:
10 to 20 mL

This dosage may be repeated every 4 to 6 hours if necessary up to 4 times in 24 hours.

Do not take more than 80 mL per day.

Panamax 240 Elixir is not recommended for children under 5 years of age.

It can be given in water if necessary.

Your doctor may ask you to take a different dose. If so, you should follow the doctor's instructions.

If you are unsure what dose to take ask your pharmacist.

If you forget to take it

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the dose you missed, and take your next dose when you are meant to.

Do not take a double dose of Panamax to make up for the dose missed.

If you take too much (Overdose)

Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 26) for advice or go to Accident and Emergency at your nearest hospital, if you think that you or anyone else has taken too much Panamax.

Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

Keep telephone numbers of these places handy.

If you take too much Panamax you may feel nauseous, dizzy or sweaty.

While you are taking Panamax

Things you must do

Take Panamax exactly as directed.

Tell all your doctors, dentists and pharmacists that you are taking Panamax.

Things you must not do

Do not take more than the recommended dose unless your doctor tells you to.

Children:
Do not give Panamax for more than 48 hours unless a doctor has told you to

Adults:
Do not take for more than a few days at a time unless your doctor tells you to.

Things to be careful of

Only drink small quantities of alcohol (beer, wine or spirits) while taking paracetamol. Drinking large quantities of alcohol while taking paracetamol may increase the risk of liver side effects.

Side Effects

Tell your pharmacist or doctor as soon as possible if you do not feel well while taking Panamax.

Like other medicines Panamax can cause some side effects. If they occur, they are most likely minor and temporary. However, sometimes they are serious, and need medical treatment.

Ask your pharmacist or doctor any questions you may have.

Tell your pharmacist or doctor if you notice any of the following and they worry you:

  • Nausea and vomiting
  • Stomach pain
  • Indigestion
  • Sweating

Tell your doctor as soon as possible if you notice any of the following:

  • Skin rashes
  • Painful red areas with blisters and peeling layers of skin which may be accompanied by fever and/or chills
  • Hepatitis (symptoms include loss of appetite, itching, yellowing of the skin and eyes, light coloured bowel motions, dark coloured urine)

If any of the following happen, tell your pharmacist or doctor immediately or go to Accident and Emergency at your nearest hospital:

  • shortness of breath
  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue or other parts of the body
  • Severe blisters and bleeding in the lips, eyes, mouth, nose and genitals
  • rash, itching or hives on the skin

The above list includes very serious side effects. You may need urgent medical attention or hospitalisation. These side effects are very rare.

Some people may get other side effects while taking Panamax.

Tell your pharmacist or doctor if you notice anything else that is making you feel unwell while taking Panamax.

After taking Panamax

Storage

Keep your tablets in the blister pack until it is time to take them. If you take the tablets out of the box or the blister pack they will not keep well.

Keep bottles tightly closed, and ensure that the child resistant cap is engaged after use.

Keep Panamax in a cool, dry place where the temperature stays below 30°C. Heat and dampness can destroy some medicines. Do not leave Panamax in the car on hot days.

Do not store Panamax or any other medicine in the bathroom or near a sink.

Keep Panamax where young children cannot reach it. A locked cupboard at least one and a half metres above the ground is a good place to store medicines.

Disposal

If your doctor tells you to stop taking Panamax, ask your pharmacist what to do with any medication which is left over.

This is not all the information available on Panamax. If you have any more questions or are not sure about anything, ask your doctor or pharmacist.

Product Description

Panamax comes as a white tablet, marked PANAMAX.

A box may contain 50 or 100 tablets.

Panamax is also available as an Elixir (100 mL) or 240 Elixir (200 mL).

Each Panamax Tablet contains:
Active Ingredient:

  • Paracetamol 500 mg

Other Ingredients:

  • Maize starch
  • Purified talc
  • Pregelatinised starch
  • Povidone
  • Stearic acid
  • Potassium sorbate

Panamax tablets do not contain gluten, lactose, sucrose, tartrazine or any azo dyes.

Panamax Elixir (100 mL) contains:
Active Ingredient:

  • Paracetamol 120 mg in 5 mL

Other Ingredients:

  • Macrogol 1500
  • Glycerol
  • Propylene Glycol
  • Potassium Sorbate
  • Benzoic Acid
  • Brilliant scarlet 4R CI 16255
  • Tutti Frutti Flavour 51880 A7
  • Raspberry Flavour 54428 A7
  • Lycasin
  • Sodium Saccharin
  • Water - Purified

Panamax 240 Elixir (200 mL) contains:
Active Ingredient:

  • Paracetamol 240 mg in 5 mL

Other Ingredients:

  • Macrogol 1500
  • Propylene Glycol
  • Potassium Sorbate
  • Benzoic Acid
  • Allura Red AC CI 16035
  • Glycerol
  • Raspberry Flavour 21820
  • Sorbitol solution 70% crystallising
  • Sodium Saccharin
  • Water - Purified
  • Imitation candied sugar 510155U

Sponsor

sanofi-aventis australia pty ltd
12-24 Talavera Road
Macquarie Park NSW 2113

AUST R 15490 (Tablets)
AUST R 13750 (Elixir)
AUST R 49623 (240 Elixir)

This leaflet was revised in October 2017

panamax-ccsiv1-cmiv11 11oct17

Published by MIMS December 2017

BRAND INFORMATION

Brand name

Panamax

Active ingredient

Paracetamol

Schedule

S2 | S3

 

1 Name of Medicine

Paracetamol.

2 Qualitative and Quantitative Composition

Panamax Tablets.

Each tablet contains paracetamol 500 mg.

Excipients with known effect.

Potassium sorbate.

Panamax Elixir.

Each 5 mL contains paracetamol 120 mg.

Excipients with known effect.

Benzoic acid, potassium sorbate, saccharin sodium.

Panamax 240 Elixir.

Each 5 mL contains paracetamol 240 mg.

Excipients with known effect.

Benzoic acid, potassium sorbate, saccharin sodium, sorbitol solution (70 per cent) (non-crystallising).
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Panamax Tablets.

Flat, round, scored, white tablet with bevelled edges, front face marking 'PANAMAX' with break line on the reverse.

Panamax Elixir.

Clear, red coloured syrup liquid with a fruity odour and taste.

Panamax 240 Elixir.

Clear light red coloured syrupy liquid.

4 Clinical Particulars

4.1 Therapeutic Indications

Relief of pain and discomfort in arthritis, headache, muscular and neuralgic conditions. Reduces fever. Panamax is useful as an analgesic for patients with dyspepsia, ulcers or gout.

4.2 Dose and Method of Administration

Panamax Tablets.

Children.

7 to 12 years.

250 to 500 mg (1/2 to 1 tablet) every four to six hours (maximum 4 tablets per day). Take with water.
Adults. 500 mg to 1 g (1 to 2 tablets) every four to six hours (maximum 8 tablets per day). Take with water.

Panamax Elixir.

Administer in water or fruit juice at 4 to 6 hourly intervals.
Infants.

1 to 3 months (4-6 kg).

2 to 4 mL.

3 to 6 months (6-8 kg).

4 to 5 mL.

6 to 12 months (8-10 kg).

5 to 6 mL.
Children.

1 to 2 years (10-12 kg).

6 to 8 mL.

2 to 4 years (12-16 kg).

8 to 10 mL.

4 to 6 years (16-20 kg).

10 to 13 mL.

6 to 8 years (20-25 kg).

13 to 16 mL.

8 to 10 years (25-32 kg).

16 to 20 mL.

10 to 12 years (32-41 kg).

20 to 26 mL.
Administration to infants under 1 month is not recommended.
Recommended dosages are based on 15 mg of paracetamol per kg of bodyweight.

Panamax 240 Elixir.

Administer in water or fruit juice if necessary.
Children.

5 to 6 years (18-20 kg).

6 mL.

6 to 8 years (20-25 kg).

6 to 8 mL.

8 to 10 years (25-32 kg).

8 to 10 mL.

10 to 12 years (32-41 kg).

10 to 12 mL.
Adults. 10 to 20 mL (maximum 80 mL per day).
If necessary repeat 4 to 6 hourly up to 4 times in 24 hours.
Panamax 240 Elixir is not recommended for children under 5 years of age.

4.3 Contraindications

Panamax is contraindicated in patients who are hypersensitive to paracetamol or to any other component of the Panamax formulations. It must not be used in patients with known glucose-6-phosphate dehydrogenase deficiency. Panamax must not be used in patients with impaired liver function.

4.4 Special Warnings and Precautions for Use

This medication may be dangerous when used in large amounts or for long periods. Hepatotoxicity may occur with paracetamol even at therapeutic doses, after short treatment duration and in patients without pre-existing liver dysfunction. Hepatotoxicity may develop following as little as 10 to 15 g of paracetamol and hepatic failure is known to occur occasionally with the long-term use of paracetamol.

To avoid the risk of overdose.

Check that paracetamol is absent from the composition of other medicinal products taken concomitantly.
Patients with known analgesic intolerance or known bronchial asthma must only use Panamax after having consulted a physician (hypersensitivity reactions including bronchospasm possible).
Caution is advised in patients with underlying sensitivity to aspirin and/or to nonsteroidal anti-inflammatory drugs (NSAIDs).

Severe cutaneous adverse reactions (SCARs).

Life threatening cutaneous reactions, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have been reported with the use of paracetamol. Patients should be advised of the signs and symptoms and monitored closely for skin reactions. If symptoms or signs of SJS and TEN (e.g. progressive skin rash often with blisters or mucosal lesions) occur, patients should stop paracetamol treatment immediately and seek medical advice.
Paracetamol should be used upon medical advice in patients with: severe renal insufficiency; chronic alcohol use including recent cessation of alcohol intake; low glutathione reserves; Gilbert's syndrome.

Use in hepatic impairment.

Panamax should not be administered to patients with hepatic dysfunction (see Section 4.3 Contraindications).

Use in renal impairment.

Panamax should not be administered to patients with renal dysfunction (see Section 4.3 Contraindications).

Use in the elderly.

No data available.

Paediatric use.

Panamax Tablet is not recommended for children under 7 years of age.
Panamax Elixir is not recommended for infants under 1 month of age.
Panamax 240 Elixir is not recommended for children under 5 years of age.

Effect on laboratory tests.

Uric acid and blood glucose.

Intake of paracetamol may affect the laboratory determination of uric acid by phosphotungstic acid and of blood glucose by glucose oxidase-peroxidase.

4.5 Interactions with Other Medicines and Other Forms of Interactions

Paracetamol may increase the risk of bleeding in patients taking warfarin and other antivitamin K. Anticoagulant dosage may require reduction and patients should be monitored for appropriate coagulation and bleeding complications.
Paracetamol absorption is increased by drugs which increase gastric emptying, e.g. metoclopramide and domperidone and decreased by drugs which decrease gastric emptying, e.g. propantheline, antidepressants with anticholinergic properties, narcotic analgesics.
Paracetamol may increase chloramphenicol concentrations by slowing down excretion, entailing the risk of increased toxicity. The risk of paracetamol toxicity may be increased in patients receiving other potentially hepatotoxic drugs or drugs that induce liver microsomal enzymes, such as antiepileptics (such as phenobarbital, phenytoin, carbamazepine, topiramate), barbiturates, hypnotics, rifampicin and alcohol.
Paracetamol excretion may be affected and plasma concentrations altered when given probenecid.
Cholestyramine reduces the absorption of paracetamol if given within 1 hour of paracetamol. Chelating resin can decrease the intestinal absorption of paracetamol and potentially decrease its efficacy if taken simultaneously. In general, there must be an interval of more than 2 hours between taking the resin and taking paracetamol, if possible.
Coadministration of flucloxacillin with paracetamol may lead to metabolic acidosis, particularly in patients presenting risk factors of glutathione depletion, such as sepsis, malnutrition or chronic alcoholism.
When used concurrently with zidovudine, an increased tendency for neutropenia may develop. Combination of Panamax and zidovudine should be avoided.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

No data available.
(Category A)
Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the foetus having been observed. Paracetamol can be used during pregnancy if clinically needed however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.
Paracetamol can cross the placenta; however, no teratogenic effects have been observed in rats or mice after doses of up to 250 mg/kg.
A woman in the third trimester of pregnancy ingested 22.5 g paracetamol; early treatment with oral acetylcysteine resulted in a good outcome for both mother and foetus.
Paracetamol is excreted in breast milk. The amount available for ingestion by the infant has been reported variously as less than 0.1% of a single 500 mg dose, and as 0.04 to 0.23% of a single 650 mg dose. Maternal ingestion of paracetamol in usual analgesic doses does not appear to present a risk to the nursing infant.

4.7 Effects on Ability to Drive and Use Machines

The effects of this medicine on a person's ability to drive and use machines were not assessed as part of its registration.

4.8 Adverse Effects (Undesirable Effects)

Reports of adverse reactions are rare. Although the following reactions have been reported: dyspepsia, sweating, erythema, urticaria, anaphylactic shock, angioneurotic oedema, difficulty breathing, drop in blood pressure, nausea, allergic reactions such as skin rashes, hypersensitivity reactions and haematological reactions, including thrombocytopenia, leukopenia, neutropenia, agranulocytosis and pancytopenia. Bronchospasm may be triggered in patients having a tendency of analgesic asthma. Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), acute generalised exanthematous pustulosis, fixed drug eruption (see Section 4.4 Special Warnings and Precautions for Use) and cytolytic hepatitis, which may lead to acute hepatic failure, have also been reported. Overdosage with paracetamol if left untreated can result in severe, sometimes fatal liver damage and rarely, acute renal tubular necrosis.
Haemolytic anaemia, particularly in patients with underlying glucose 6-phosphate-dehydrogenase deficiency has been reported. Kounis syndrome has been reported, as has pyroglutamic acidosis in patients with pre-disposing factors for glutathione depletion.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at http://www.tga.gov.au/reporting-problems.

4.9 Overdose

Elderly persons, small children, patients with liver disorders, chronic alcohol consumption or chronic malnutrition, as well as patients concomitantly treated with enzyme-inducing drugs are at an increased risk of intoxication, including fatal outcome.

Symptoms.

Toxic symptoms include vomiting, abdominal pain, hypotension and sweating. Nausea, vomiting, anorexia, pallor and abdominal pain generally appear during the first 24 hours of overdosage with paracetamol. Overdosage with paracetamol may cause hepatic cytolysis which can lead to hepatocellular insufficiency, gastrointestinal bleeding, metabolic acidosis, encephalopathy, disseminated intravascular coagulation, coma and death. Increased levels of hepatic transaminases, lactate dehydrogenase and bilirubin with a reduction in prothrombin level can appear 12 to 48 hours after acute overdosage. Overdosage can also lead to pancreatitis, acute renal failure and pancytopenia. The most serious adverse effect of acute overdosage of paracetamol is a dose dependent, potentially fatal hepatic necrosis. In adults, hepatotoxicity may occur after ingestion of a single dose of 12 g (24 tablets) of paracetamol; a dose of 25 g (50 tablets) or more is potentially fatal. Symptoms during the first 2 days of acute poisoning by paracetamol do not reflect the potential seriousness of the intoxication. Major manifestations of liver failure such as jaundice, hypoglycaemia and metabolic acidosis may take at least 3 days to develop.

Treatment.

Despite lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention.
Determinations of the plasma concentration of paracetamol are recommended.
Plasma concentration of paracetamol should be measured at 4 hours or later after ingestion (earlier concentrations are unreliable).
Where paracetamol intoxication is suspected, intravenous administration of SH group donators such as acetylcysteine within the first 10 hours after ingestion is indicated. Although acetylcysteine is most effective if initiated within this period, it can still offer some degree of protection if given as late as 48 hours after ingestion; in this case it is taken for longer.
If the history suggests that 12 g paracetamol or more has been ingested, administer one of the following antidotes.

Acetylcysteine 20% i.v.

Administer intravenously, 20% acetylcysteine immediately without waiting for positive urine test or plasma level results. For dosage instructions refer to the acetylcysteine 20% i.v. product information.

Oral methionine.

For dosage instructions refer to the methionine product information.
Further measures will depend on the severity, nature and course of clinical symptoms of intoxication and should follow standard intensive care protocols.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Paracetamol has analgesic and antipyretic effects.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Absorption.

After oral administration, paracetamol is absorbed rapidly and completely from the small intestine; peak plasma levels occur 10 to 60 minutes after oral administration. Food intake delays paracetamol absorption.

Distribution.

Paracetamol is uniformly distributed throughout most body fluids; the apparent volume of distribution is 1 to 1.2 L/kg. Paracetamol can cross the placenta and is excreted in breast milk. Plasma protein binding is negligible at usual therapeutic concentrations but increases with increasing concentrations.

Metabolism.

Paracetamol is metabolised by the hepatic microsomal enzyme system. In adults at therapeutic doses, paracetamol is mainly conjugated with glucuronide (45-55%) or sulfate (20-30%). A minor proportion (less than 20%) is metabolised to catechol derivatives and mercapturic acid compounds via oxidation. Paracetamol is metabolised differently by infants and children compared to adults, the sulfate conjugate being predominant.

Excretion.

Paracetamol is excreted in the urine mainly as the glucuronide and sulfate conjugates. Less than 5% is excreted as unchanged paracetamol. 85-90% of the administered dose is eliminated in the urine within 24 hours of ingestion.
The elimination half-life is about 1 to 4 hours.

5.3 Preclinical Safety Data

Genotoxicity.

No data available.

Carcinogenicity.

No data available.

6 Pharmaceutical Particulars

6.1 List of Excipients

Panamax Tablets.

The inactive ingredients are: maize starch, purified talc, pregelatinised maize starch, povidone, stearic acid and potassium sorbate.

Panamax Elixir.

The inactive ingredients are: macrogol 1500, propylene glycol, glycerol, tutti frutti flavour, raspberry flavour, benzoic acid, potassium sorbate, Lycasin, saccharin sodium, ponceau SX and purified water.

Panamax 240 Elixir.

The inactive ingredients are: macrogol 1500, allura red AC, propylene glycol, glycerol, saccharin sodium, sorbitol solution (70 per cent) (non-crystallising), benzoic acid, potassium sorbate, raspberry flavour, imitation candied sugar and purified water.

6.2 Incompatibilities

Incompatibilities were either not assessed or not identified as part of the registration of this medicine.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 30°C.

6.5 Nature and Contents of Container

Panamax Tablet.

Blister packs of 50 and 100 tablets.

Panamax Elixir.

100 mL.

Panamax 240 Elixir.

200 mL.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking to your local pharmacy.

6.7 Physicochemical Properties

Paracetamol is a white or almost white, crystalline powder. It is sparingly soluble in water, freely soluble in alcohol and very slightly soluble in methylene chloride. It has a melting point between 168°C and 172°C.

Chemical structure.


MW: 151.17.

Chemical formula.

C8H9NO2.

Chemical name.

N-(4-Hydroxyphenyl) acetamide.

CAS number.

103-90-2.

7 Medicine Schedule (Poisons Standard)

Panamax Tablet.

Pharmacy Medicine (Schedule 2) pack size: 50.
Pharmacist Only Medicine (Schedule 3) pack size: 100.

Panamax Elixir and Panamax 240 Elixir.

Pharmacy Medicine (Schedule 2).

Summary Table of Changes